SPG601 is a once-a-day pill that works by restoring synaptic function to address core symptoms of Fragile X Syndrome SPG601 is a once-a-day pill that works by restoring synaptic function to address core symptoms of Fragile X Syndrome The post Spinogenix Announces U.S. FDA Approval of its Investigational New Drug Application for its Phase 2a……
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives -Adenosine clinical development paused Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
ZURICH, Switzerland, April 15, 2024 (GLOBE NEWSWIRE) — BC Platforms (BCP), a global leader in real world data, healthcare data management, and analytics, today announces an exclusive collaboration with NTT Life Science Corporation, a company in the medical field of the NTT Group, to accelerate data-driven medicine. Last week, in Japan, an official opening ceremony…
SØBORG, Dänemark, April 15, 2024 (GLOBE NEWSWIRE) — Cbio A/S – Pionier im Bereich T-Zell-Therapien der nächsten Generation für solide Tumore, gibt Finanzergebnisse für 2023 und aktuelle Unternehmensdaten bekannt. Cbio A/S, Entwickler von T-Zell-Therapien, stellt im Rahmen der Vorbereitungen zur klinischen Studie den Jahresbericht 2023 vor und kündigt mit einer gesicherten Finanzierung in Höhe von…
Soligenix announced today that the Office of Orphan Products Development of the United States (U.S.) Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient in MarVax™, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for „the prevention and post-exposure prophylaxis against MARV infection.“ MarVax™ is a subunit…
Premature deaths related to opioids doubled between 2019 and 2021 across Canada, with more than 1 in 4 deaths among young adults aged 20–39 years attributable to opioids, according to new research published in CMAJ (Canadian Medical Association Journal) Opioid-related deaths have continued to increase over the past decade across Canada, with 6222 deaths occurring…
The Global Theranostics Market Size is to Grow from USD 1.9 Billion in 2023 to USD 3.3 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.68% during the projected period. Theranostics is a type of pharmaceutical treatment used in combination with diagnostics to maximize efficacy, safety, and expedite the discovery of new…
The Global Deepfake AI Market Size was Valued at USD 6.83 Billion in 2023 and the Worldwide Deepfake AI Market Size is Expected to Reach USD 119.34 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Deepfake AI, or deep learning-based fake artificial intelligence, is the use of strong machine…
In einem Artikel in der Zeitschrift JAMA Pediatrics wurde festgestellt, dass der generative KI-Chatbot ChatGPT von OpenAI, den einige Gesundheitsorganisationen für begrenzte Anwendungsfälle getestet haben, bei der Diagnose pädiatrischer Krankheiten in 83 % der Fälle Fehler macht . Und beim Testen von OpenAIs GPT-4 als Diagnoseassistent stellten Ärzte am Beth Israel Deaconess Medical Center in…
Ein künstliches Gehirn aus dem Labor mag wie reine Science-Fiction klingen, doch ein japanisch-französisches Forschungsteam hat nun tatsächlich eine Technik entwickelt, um laborgezüchtete gehirnähnliche Gewebe miteinander zu verbinden. In einer Studie im Fachmagazin Nature Communications vergleichen sie ihren Aufbau mit den Schaltkreisen im menschlichen Gehirn. Laborzucht von Gehirnzellen Die Forscher des Institute of Industrial Science…
